Part 10: Acute Coronary Syndromes 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care

被引:192
作者
O'Connor, Robert E.
Brady, William
Brooks, Steven C.
Diercks, Deborah
Egan, Jonathan
Ghaemmaghami, Chris
Menon, Venu
O'Neil, Brian J.
Travers, Andrew H.
Yannopoulos, Demetris
机构
关键词
acute coronary syndrome; myocardial infarction; non-ST-segment elevation acute coronary syndromes; ACUTE MYOCARDIAL-INFARCTION; ST-SEGMENT-ELEVATION; DOOR-TO-BALLOON; MOLECULAR-WEIGHT HEPARIN; HOSPITAL CARDIAC-ARREST; ACUTE CHEST-PAIN; PRIMARY VENTRICULAR-FIBRILLATION; TISSUE-PLASMINOGEN-ACTIVATOR; CONVERTING ENZYME-INHIBITION; ORAL ANTIPLATELET THERAPY;
D O I
10.1161/CIRCULATIONAHA.110.971028
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There has been tremendous progress in reducing disability and death from ACS. But many patients still die before reaching the hospital because patients and family members fail to recognize the signs of ACS and fail to activate the EMS system. Once the patient with ACS contacts the healthcare system, providers must focus on support of cardiorespiratory function, rapid transport, and early classification of the patient based on ECG characteristics. Patients with STEMI require prompt reperfusion; the shorter the interval from symptom onset to reperfusion, the greater the benefit. In the STEMI population, mechanical reperfusion with percutaenous coronary intervention improves survival and decreases major cardiovascular events compared to fibrinolysis. Patients with UA/NSTEMI (non-STEMI ACS) or nonspecific or normal ECGs require risk stratification and appropriate monitoring and therapy. Healthcare providers can improve survival rates and myocardial function of patients with ACS by providing skilled, efficient, and coordinated out-ofhospital and in-hospital care. © 2010 American Heart Association. All rights reserved.
引用
收藏
页码:S787 / S817
页数:31
相关论文
共 397 条
[31]  
ATHAPPAN G, 2009, INT J CARDIOL
[32]   Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock [J].
Babaev, A ;
Frederick, PD ;
Pasta, DJ ;
Every, N ;
Sichrovsky, T ;
Hochman, JS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (04) :448-454
[33]  
Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
[34]   ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither [J].
Baigent, C ;
Collins, R ;
Appleby, P ;
Parish, S ;
Sleight, P ;
Peto, R .
BMJ-BRITISH MEDICAL JOURNAL, 1998, 316 (7141) :1337-1343
[35]  
Banerjee S, 1998, J ROY COLL PHYS LOND, V32, P36
[36]   Outcome of myocardial infarction in patients treated with aspirin is enhanced by pre-hospital administration [J].
Barbash, IM ;
Freimark, D ;
Gottlieb, S ;
Hod, H ;
Hasin, Y ;
Battler, A ;
Crystal, E ;
Matetzky, S ;
Boyko, V ;
Mandelzweig, L ;
Behar, S ;
Leor, J .
CARDIOLOGY, 2002, 98 (03) :141-147
[37]  
Bassan Roberto, 2004, Crit Pathw Cardiol, V3, P1, DOI 10.1097/01.hpc.0000116581.65736.1b
[38]  
Basu S, 1997, CIRCULATION, V96, P183
[39]  
Bazzino O, 1998, NEW ENGL J MED, V338, P1498
[40]   Stress echo in chest pain unit: the SPEED trial [J].
Bedetti, G ;
Pasanisi, EM ;
Tintori, G ;
Fonseca, L ;
Tresoldi, S ;
Minneci, C ;
Jambrik, Z ;
Ghelarducci, B ;
Orlandini, A ;
Picano, E .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 102 (03) :461-467